SFC Capital backed the pre-seed round to help advance the company's know your network platform.
"Financial crime is becoming increasingly sophisticated and difficult to fight. The work Schwarzthal Tech is doing is already helping tackle financial crime and we are proud to be a partner on their journey. Marius-Cristian’s vast knowledge on the subject and incredible experience in financial crime research puts the company a step ahead of others in the sector: he already knows what needs to be done."
Equable Capital led the Series B round to support the identity verification provider in growing its operations across North America and EMEA.
"2021 was an incredible year for OCR Labs, with continued validation from customers who have chosen us as their provider for online digital identity verification. This investment provides us with the capital to continue our growth while bringing a value-added investor on to our board. Our vision remains unchanged: we strive to be the leading technology provider of digital identity verification, globally. The market opportunity continues to grow, and with our expansion in the US, and investment in our global sales effort, we’re in a phenomenal position to grow our customer base."
The seed round was backed by investors including 5 Lion Ventures and Ascension Ventures to support team growth and product development.
"As AR adoption accelerates, and the metaverse jumps from science fiction to reality, we’re excited to offer today’s mobile users a glimpse of an inevitable future that combines our physical selves with the metaverse through Beem,"
The extension features participation from MMC Ventures and a new key investor.
"The range of existing and new investors is a fantastic endorsement of both our strategy and the global applicability of the solutions we provide to solve a need in the market. This extended funding will give us the ability to focus upon growth in both Asia and in the U.K. We have been expanding the team to support this and signing new partnerships in the region, such as the recently announced involvement with AIA Group, Asia’s largest pan-Asian Life Insurer."
The pre-seed round was co-led by IQ Capital and Ahren Innovation Capital to support team expansion and technology validation.
"Our ability to take a sample from someone with an unknown infection and answer the open question 'what do they have?' within a minute is a gamechanger for infection diagnosis and treatment. We’ll start with respiratory viruses and expand from there. In parallel, we’ll be simplifying the workflow to move the test from the lab to point of care, which will represent a step change in the availability and cost of infectious disease diagnostics worldwide."
.png)
